symptoms of COVID-19 patients. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Patients with Covid-19 will consume 10 ml of syrup containing aqueous extracts of Ador-Cancer, saffron petals and mountain tea 3 times a day. In this study, no spec
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria in this study include all patients who have been diagnosed with Covid 19 infection and do not have other infections or diseases such as influenza, pulmonary insufficiency, ARDS pneumonia and other cold symptoms, as well as files with complete data. Consciously taken from patients.
Exclusion criteria
Exclusion criteria: Exclusion criteria included patients who had other infections or diseases such as influenza, pulmonary insufficiency, ARDS pneumonia and other cold symptoms and the result of Qovid 19 infection is negative. Also, files with incomplete data will be removed from this study. Obviously, conscious dissatisfaction also leads to exclusion from the study. Patients who were hospitalized and their clinical condition was deteriorating were excluded from the study and lung CT scans were obtained from patients. Patients with oxygen levels less than 93 mm Hg were excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The length of hospitalization of patients with Covid-19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record.;The mortality in patients with Covid-19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record.;The pulmonary infiltration in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: With CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects from the use of herbal compounds (COVID-herbs). Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Refer to the medical file and complete a special questionnaire for complications.;The liver function in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of SGOT and SGPT enzymes using ELISA kit.;The kidney function in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of chemical parameters such as BUN and Creatinine by colorimetric method with autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Drehkordi
Rafsanjan University of Medical Sciences
Outcome results
None listed